Genome-wide profiling of N6-methyladenosine-modified pseudogene-derived long noncoding RNAs reveals the tumour-promoting and innate immune-restraining function of RPS15AP12 in ovarian cancer

Jie Xu , Yifei Ren , Jiayi Lu , Fengjiang Qin , Dan Yang , Chunyan Tang , Yu Yang , Jing Xu , Tao Liu , Ping Yi

Clinical and Translational Medicine ›› 2025, Vol. 15 ›› Issue (3) : e70249

PDF
Clinical and Translational Medicine ›› 2025, Vol. 15 ›› Issue (3) : e70249 DOI: 10.1002/ctm2.70249
RESEARCH ARTICLE

Genome-wide profiling of N6-methyladenosine-modified pseudogene-derived long noncoding RNAs reveals the tumour-promoting and innate immune-restraining function of RPS15AP12 in ovarian cancer

Author information +
History +
PDF

Abstract

•Genome-wide profiling reveals the redistribution of m6A modification on pseudogene-derived lncRNAs and m6A redistribution-relevant dysregulation of pseudogenes in HGSOC.

•RPS15AP12, as a representative processed pseudogene, is up-regulated by FTO-mediated demethylation and acts as a miRNA sponge to promote RPS15A expression via competitively binding to miR-96-3p.

•RPS15AP12/RPS15A axis inhibits MAVS sensors (RIG-I and MDA5) and downstream IFN-β levels in ovarian cancer.

Keywords

innate immune response / m 6A / miRNA sponge / ovarian cancer / pseudogene

Cite this article

Download citation ▾
Jie Xu, Yifei Ren, Jiayi Lu, Fengjiang Qin, Dan Yang, Chunyan Tang, Yu Yang, Jing Xu, Tao Liu, Ping Yi. Genome-wide profiling of N6-methyladenosine-modified pseudogene-derived long noncoding RNAs reveals the tumour-promoting and innate immune-restraining function of RPS15AP12 in ovarian cancer. Clinical and Translational Medicine, 2025, 15(3): e70249 DOI:10.1002/ctm2.70249

登录浏览全文

4963

注册一个新账户 忘记密码

References

RIGHTS & PERMISSIONS

2025 The Author(s). Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.

AI Summary AI Mindmap
PDF

93

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/